Medication info
Wellbutrin XL Tablet 300 Milligrams (Bupropion Hydrochloride)

Wellbutrin XL Tablet 300 Milligrams (Bupropion Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Bupropion Hydrochloride›300mg / 1 tablet
Manufacturer / importer
GSK Korea
Appearance
White to pale yellow round extended-release film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200702570 · Approved 2007.03.02 · Insurance code 650000930

Summary

Main use
Treatment of major depressive disorder
Who takes it
Adults
Adult dose
This drug should be swallowed whole; do not crush, split, or chew it. Doing so may increase the risk of adverse reactions, including seizures. It is particularly important to administer this drug in a way that minimizes the risk of seizures. It is also important to increase the dose gradually to minimize agitation, extremely restless behavior, and insomnia, which are frequently observed at the beginning of treatment. If necessary, these effects may be managed by temporarily reducing the dose or by short-term administration of a sedative-hypnotic with an intermediate or long duration of action; however, a sedative-hypnotic is usually not needed after the first week of treatment. Avoiding administration near bedtime may minimize insomnia, and dose escalation should be stopped if the patient reports distress due to persistent adverse reactions. 1. Initial dose The usual target dose of this drug for adults is 300mg/day, administered once in the morning. Administer 150mg of this drug once in the morning for at least 4 days; if the patient tolerates it adequately, increase the dose to 300mg once daily, allowing an interval of at least 24 hours between doses. 2. Maintenance dose It is generally accepted that drug therapy for an acute episode of depression should continue for several months or longer after treatment of the acute episode. It is not possible to determine whether the dose of this drug required for maintenance therapy is the same as the dose needed to achieve the initial response. Therefore, patients should be reassessed regularly to determine whether maintenance therapy is necessary and what dose is appropriate for maintenance therapy. 3. Switching to this drug in patients receiving bupropion hydrochloride sustained-release tablets Switching to this drug in patients receiving bupropion hydrochloride sustained-release tablets is possible only when the total daily dose is the same. Patients currently taking bupropion hydrochloride sustained-release tablets at a dose of 300mg/day (for example, 150mg twice daily) may switch to taking this drug 300mg once daily. ㆍPatients with hepatic impairment Use this drug with extreme caution in patients with severe cirrhosis, and do not exceed 150mg every 2 days in these patients. Use this drug with caution in patients with hepatic impairment (including mild to moderate cirrhosis); in patients with mild to moderate cirrhosis, consider reducing the dosing frequency and/or dose. ㆍPatients with renal impairment Use this drug with caution in patients with renal impairment, and consider reducing the dosing frequency and/or dose.

Ingredients

Importer
GSK Korea

Efficacy & effects

Treatment of major depressive disorder

  • Major depressive disorder
View approved original text

This medication is used for major depressive disorder.

How to take

Adult dose

This drug should be swallowed whole; do not crush, split, or chew it. Doing so may increase the risk of adverse reactions, including seizures. It is particularly important to administer this drug in a way that minimizes the risk of seizures. It is also important to increase the dose gradually to minimize agitation, extremely restless behavior, and insomnia, which are frequently observed at the beginning of treatment. If necessary, these effects may be managed by temporarily reducing the dose or by short-term administration of a sedative-hypnotic with an intermediate or long duration of action; however, a sedative-hypnotic is usually not needed after the first week of treatment. Avoiding administration near bedtime may minimize insomnia, and dose escalation should be stopped if the patient reports distress due to persistent adverse reactions. 1. Initial dose The usual target dose of this drug for adults is 300mg/day, administered once in the morning. Administer 150mg of this drug once in the morning for at least 4 days; if the patient tolerates it adequately, increase the dose to 300mg once daily, allowing an interval of at least 24 hours between doses. 2. Maintenance dose It is generally accepted that drug therapy for an acute episode of depression should continue for several months or longer after treatment of the acute episode. It is not possible to determine whether the dose of this drug required for maintenance therapy is the same as the dose needed to achieve the initial response. Therefore, patients should be reassessed regularly to determine whether maintenance therapy is necessary and what dose is appropriate for maintenance therapy. 3. Switching to this drug in patients receiving bupropion hydrochloride sustained-release tablets Switching to this drug in patients receiving bupropion hydrochloride sustained-release tablets is possible only when the total daily dose is the same. Patients currently taking bupropion hydrochloride sustained-release tablets at a dose of 300mg/day (for example, 150mg twice daily) may switch to taking this drug 300mg once daily. ㆍPatients with hepatic impairment Use this drug with extreme caution in patients with severe cirrhosis, and do not exceed 150mg every 2 days in these patients. Use this drug with caution in patients with hepatic impairment (including mild to moderate cirrhosis); in patients with mild to moderate cirrhosis, consider reducing the dosing frequency and/or dose. ㆍPatients with renal impairment Use this drug with caution in patients with renal impairment, and consider reducing the dosing frequency and/or dose.

Precautions

This medication may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults with major depressive disorder or other psychiatric disorders. This medication should not be used in combination with other bupropion-containing medications for smoking cessation or depression treatment. Patients with hypersensitivity to this medication or a history of seizures, patients with CNS tumors, patients at risk of seizures after alcohol withdrawal, and patients with bulimia or anorexia nervosa should not take this medication. Additionally, patients currently taking MAO inhibitors or other medications including bupropion should avoid use. Patients at risk of seizures must strictly adhere to the dosage of this medication, and should use with caution if they have a history of seizures or are taking other medications that increase seizure risk. Patients with impaired liver or kidney function may be affected in the metabolism and excretion of this medication, necessitating dosage adjustment and close monitoring. The safety of this medication in patients with cardiovascular diseases has not been fully established, so caution is advised during use. If an allergic reaction occurs during treatment, discontinue use immediately and consult a physician. This medication may cause side effects such as anxiety, insomnia, headaches, dizziness, nausea, dry mouth, tremors, and malaise, and in severe cases, psychotic symptoms or seizures may occur, so careful observation is required. Women who are pregnant or planning to become pregnant should consult their doctor before taking this medication, and nursing mothers are advised to avoid taking it. The use of this medication is not approved for children and adolescents under 18 years of age, and dosage adjustment may be necessary in elderly patients considering the possibility of kidney function decline. In case of overdose, serious side effects and an increased risk of seizures may occur, requiring immediate medical attention for appropriate treatment. This medication requires caution when driving or operating machinery, and the risk of side effects may increase when taken with alcohol or other central nervous system depressants, so these should be avoided. Finally, this medication may interact with other drugs, so it is essential to inform your physician about any other medications you are taking.

Side effects

Abdominal pain, accidental injury, chest pain, neck pain, facial swelling, hypertension, palpitations, nausea, dry mouth, constipation, diarrhea, loss of appetite, oral ulcers, thirst, myalgia, arthralgia, insomnia, abnormal dreams, anxiety, concentration difficulties, dizziness, irritability, tremors, discomfort, rhinitis, increased cough, pharyngitis, sinusitis, dyspnea, epistaxis, reaction at patch application site, rash, itching, urticaria, dysgeusia, tinnitus, headache, infection, lethargy, pain, fever, flushing, tachycardia, elevated blood pressure, orthostatic hypotension, vasodilation, syncope, hypotension, abnormal dreams, memory impairment, abnormal sensations, headache, agitation, restlessness, depression, confusion, delusions, paranoid thinking, hallucinations, hypersensitivity, hostility, aggression, seizures, depersonalization, Parkinsonism, dystonia, ataxia, muscle fasciculation, inability to cooperate, stuttering, panic attacks, blood sugar disorders, weight loss, hyponatremia, vomiting, elevated liver enzyme levels, jaundice, hepatitis, frequent urination, urinary retention, urinary incontinence, angioedema, anaphylactic shock, erythema multiforme, Stevens-Johnson syndrome, exacerbation of systemic lupus erythematosus, cutaneous lupus erythematosus, acute generalized pustular psoriasis, visual disturbances, vaginal bleeding, urinary tract infection, migraine, diarrhea, dysphagia, spasms, drowsiness, hypersensitivity, memory decrease, central nervous system excitation, flashes, pharyngitis, sinusitis, sweating, fever, chills, facial swelling, musculoskeletal chest pain, photophobia, fatigue, stroke, myocardial infarction, phlebitis, pulmonary edema, bruxism, gastroesophageal reflux, gingivitis, glossitis, increased salivation, tongue swelling, colitis, esophagitis, gastrointestinal bleeding, gingival bleeding, liver damage, pancreatitis, gastric ulcer, leg cramps, muscle rigidity, rhabdomyolysis, muscle weakness, coordination abnormalities, decreased libido, discomfort, emotional instability, hyperactivity, sensory deficits, suicidal thoughts, dizziness, amnesia, ataxia, unreality, hypomania, abnormal EEG, inability to move, aphasia, coma, suicide, delirium, speech disorders, involuntary movements, relief, extrapyramidal syndrome, decreased activity, increased libido, manic reactions, neuralgia, neuropathy, paranoid thinking, suicide attempts, tardive dyskinesia, bronchospasm, pneumonia, erectile dysfunction, polyuria, prostate disorders, ejaculation abnormalities, cystitis, dyspareunia, dysuria, gynecomastia, menopause, pain during erection, salpingitis, vaginitis, hyperglycemia, hypoglycemia, inappropriate antidiuretic hormone syndrome, edema, peripheral edema, diabetes, petechiae, anemia, leukocytosis, leukopenia, lymphadenopathy, pancytopenia, thrombocytopenia, papular rash, alopecia, exfoliative dermatitis, hirsutism, pupillary control abnormalities, dry eyes, hearing loss, diplopia, increased intraocular pressure, mydriasis, insomnia, headache, dizziness, nausea, anxiety, agitation, tremors, irritability, drowsiness, delirium, muscle rigidity, depression, hallucinations, confusion, diarrhea, erectile dysfunction, discomfort, agitation, vomiting, chest pain, dyspnea, pharyngitis, visual disturbances, weight loss, schizophrenic reactions, Parkinsonism, depersonalization, pancreatitis, sequelae of intracranial injury, fractures, prostate abnormalities, bipolar disorder, confusion, bipolar disorder, pneumonia, alcohol dependence, skin disorders, seizures, coma, movement disorders, paralysis, anaphylactic shock, vomiting, rash, diabetes, dyspnea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1°C and 30°C at room temperature. This helps to preserve the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White to pale yellow round extended-release film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.